We hypothesized that the longevity‐associated FOXO3 genotype would be associated with a sizable risk reduction for mortality and with one or more major age‐associated clinical causes of death, such as coronary heart disease (CHD), cancer, and stroke. Here, FOXO3 is linked to stroke disorder.